BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 201324)

  • 1. Characteristics of (-)-[3H]-dihydroalprenolol binding to beta-adrenoceptors on rat lung membranes [proceedings].
    Barnett DB; Nahorski SR; Rugg EL
    Br J Pharmacol; 1977 Nov; 61(3):459P. PubMed ID: 201324
    [No Abstract]   [Full Text] [Related]  

  • 2. Pitfalls in the assessment of the specific binding of(-)[3H]-dihydroalprenolol to beta-adrenoceptors [proceedings].
    Nahorski SR; Richardson A
    Br J Pharmacol; 1979 Jul; 66(3):469P-470P. PubMed ID: 230879
    [No Abstract]   [Full Text] [Related]  

  • 3. Irreversible blockade of beta adrenoreceptors and their recovery in the rat heart and lung in vivo.
    Baker SP; Pitha J
    J Pharmacol Exp Ther; 1982 Feb; 220(2):247-51. PubMed ID: 6120224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of (3H)dihydroalprenolol to beta adrenoceptors of cells isolated from adult rat heart.
    Moustafa E; Giachetti A; Downey HF; Bashour FA
    Naunyn Schmiedebergs Arch Pharmacol; 1978 May; 303(1):107-9. PubMed ID: 209345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]dihydroalprenolol binding in the rat brainstem.
    Stone EA; U'Prichard DC
    Eur J Pharmacol; 1981 Oct; 75(2-3):159-61. PubMed ID: 6119217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identity of [3H]-dihydroalprenolol binding sites and beta-adrenergic receptors coupled with adenylate cyclase in the central nervous system: pharmacological properties, distribution and adaptive responsiveness.
    Dolphin A; Adrien J; Hamon M; Bockaert J
    Mol Pharmacol; 1979 Jan; 15(1):1-15. PubMed ID: 218089
    [No Abstract]   [Full Text] [Related]  

  • 7. Direct evidence of two types of beta adrenoceptor binding site in lung tissue.
    Barnett DB; Rugg EL; Nahorski SR
    Nature; 1978 May; 273(5658):166-8. PubMed ID: 25391
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of phospholipids on the binding of [3H]dihydroalprenolol to the beta-adrenergic receptor of rabbit heart membranes.
    Thang NX; Borsodi A; Wollemann M
    Biochem Pharmacol; 1980 Oct; 29(20):2791-7. PubMed ID: 6254538
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo receptor binding of iodinated beta-adrenoceptor blockers.
    Eckelman WC; Gibson RE; Vieras F; Rzeszotarski WJ; Francis B; Reba RC
    J Nucl Med; 1980 May; 21(5):436-42. PubMed ID: 6103024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of mammalian beta-adrenoreceptors by use of macromolecular alprenolol derivatives. A comparison with amphibian erythrocyte receptors.
    Kusiak JW; Pitha J
    Biochem Pharmacol; 1982 Jun; 31(11):2071-6. PubMed ID: 6180753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of beta-adrenergic receptors in rat parotid membranes.
    Au DK; Malbon CC; Butcher FR
    Biochim Biophys Acta; 1977 Dec; 500(2):361-71. PubMed ID: 201297
    [No Abstract]   [Full Text] [Related]  

  • 12. (+/-)-[3H]Epinephrine and (-)[3H]dihydroalprenolol binding to beta1- and beta2-noradrenergic receptors in brain, heart, and lung membranes.
    U'Prichard DC; Bylund DB; Snyder SH
    J Biol Chem; 1978 Jul; 253(14):5090-102. PubMed ID: 209026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homogeneity of beta 2-adrenoceptors on rat erythrocytes and reticulocytes. A comparison with heterogeneous rat lung beta-adrenoceptors.
    Dickinson K; Richardson A; Nahorski SR
    Mol Pharmacol; 1981 Mar; 19(2):194-204. PubMed ID: 6112660
    [No Abstract]   [Full Text] [Related]  

  • 14. Methodological aspects of receptor research: problems in the assessment of specific and non-specific binding of 3H-dihydroalprenolol to bovine lung membranes.
    Richardson A; Nahorski SR
    Eur J Respir Dis Suppl; 1984; 135():114-23. PubMed ID: 6329797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-adrenergic receptors in brown adipose tissue: identification by (-)[3H]dihydroalprenolol binding.
    Bukowiecki LJ; Caron MG; Vallieres J; LeBlanc J
    Experientia Suppl; 1978; 32():55-9. PubMed ID: 206459
    [No Abstract]   [Full Text] [Related]  

  • 16. Binding of 3H-dihydroalprenolol to beta-adrenoceptors in adipocytes of spontaneously hypertensive rats and essentially hypertensive patients.
    Boriskina GM; Postnov YuV
    Experientia; 1982 Feb; 38(2):263-4. PubMed ID: 6277685
    [No Abstract]   [Full Text] [Related]  

  • 17. Associations of [3H]dihydroalprenolol with biological membranes.
    Mendel CM; Almon RR
    Gen Pharmacol; 1979; 10(1):31-40. PubMed ID: 33101
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta-adrenergic receptors in early human placenta characterization of [3H]-dihydroalprenolol binding.
    Falkay G; Kovacs L
    Life Sci; 1983 Apr; 32(14):1583-90. PubMed ID: 6300586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-adrenoceptors of human lymphocytes: decrease in affinity of agonist for (-)3h-dihydroalprenolol binding sites by cytoplasmic fractions.
    Watanabe Y; Lai RT; Higuchi H; Maeda H; Yoshida H
    Life Sci; 1981 Mar; 28(12):1399-405. PubMed ID: 6264246
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of beta-adrenoceptors in bovine intracerebral microvessels and cerebral grey matter by [3H]dihydroalprenolol binding.
    Culvenor AJ; Jarrott B
    Neuroscience; 1981; 6(8):1643-8. PubMed ID: 6267511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.